PrEP research: Why pregnant, lactating women shouldn’t be excluded – Expert

PrEP research: Why pregnant, lactating women shouldn’t be excluded – Expert

The Executive Director of New HIV Vaccine and Microbicide Advocacy Society (NHVMAS), Mrs Florita Durueke, has called for the inclusion of pregnant and lactating women in the HIV clinical trial intervention for pre-exposure prophylaxis (PrEP) saying their involvement would help in the reduction of HIV as they face substantial risk of HIV infection. 

Speaking in one of the just concluded five-day webinar series by the organisation, Durueke recalled that  there is a growing consensus globally around the ethical and public health imperative for the responsible inclusion of pregnant women and lactating mothers in clinical research.

She said: “there is a need to develop ethics guidelines for the inclusion of pregnant women and lactating mothers in HIV/co-infections research.

“World Health Organisation, WHO, in partnership with MPACT has identified these gaps and they have developed a framework that stipulates that pregnant women and breastfeeding mothers can participate in research, especially at the face two. They design a situation that if a woman is faced with two trials, at the cost of the trial becoming pregnant she discontinues.

“When we did the trial in Lagos, one of the criteria is that you are not going to get pregnant for that period, so if the person gets pregnant she will discontinue.

“But the WHO framework is saying when a person gets pregnant in an HIV prevention trial, they should offer the person the opportunity to decide if she is willing to continue in the research and if the person says yes, then they should allow the person and then collect the data,” Durueke said.

While calling for advanced responsible HIV prevention research in pregnant and lactating populations, PLP, using a Reproductive Justice, she said that there is a need to engage stakeholders in an early, sustained, and meaningful way in designing and conduct a biomedical HIV prevention trials tailored to the distinctive complexities of research with PLP.

She also advocated sound ethics review processes that promote the responsible inclusion of PLP, including adolescent girls and young women, in biomedical HIV prevention research.

About author

You might also like

NAFDAC procures 73 utility vehicles to check fake drugs, unwholesome food products

  In its renewed efforts to rid the nation of falsified and counterfeit medicines, unwholesome food and cosmetic products, the National Agency for Food and Drug Administration and Control, NAFDAC

Zika virus set to spread across Americas

The mosquito-borne Zika virus, which has been linked to brain damage in thousands of babies in Brazil, is likely to spread to all countries in the Americas except for Canada

WHO report shows poorer health outcomes for vulnerable refugees, migrants

Says World may not achieve SDGs health-related goals  The first World Health Organisation’s, WHO, report on the health of refugees and migrants has shown that globally, millions of refugees and

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply